Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Patients with a first episode of unprovoked venous thromboembolism have a high risk of recurrence after discontinuation of anticoagulant therapy. Extending anticoagulation reduces the risk of recurrence but is associated with increased bleeding. Sulodexide, a glycosaminoglycan, exerts antithrombotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreozzi, Giuseppe M., Bignamini, Angelo A., Davì, Giovanni, Palareti, Gualtiero, Matuška, Jiří, Holý, Martin, Pawlaczyk-Gabriel, Katarzyna, Džupina, Andrej, Sokurenko, German Y., Didenko, Yury P., Andrei, Laurentia D., Lessiani, Gianfranco, Visonà, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643750/
https://www.ncbi.nlm.nih.gov/pubmed/26408273
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.016930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643750/
https://www.ncbi.nlm.nih.gov/pubmed/26408273
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.016930

Ejemplares similares